-+ 0.00%
-+ 0.00%
-+ 0.00%

TD Cowen Maintains Hold on Legend Biotech, Lowers Price Target to $24

Benzinga·08/12/2026 15:18:59
Listen to the news
TD Cowen analyst Yaron Werber maintains Legend Biotech (NASDAQ:LEGN) with a Hold and lowers the price target from $29 to $24.